Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Nanofiber Materials for Biomedical Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Nanofiber Materials for Biomedical Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Synthetic polymers
      • 1.3.3 Natural polymers
      • 1.3.4 Ceramic and inorganic
      • 1.3.5 Carbon and graphene
      • 1.3.6 Metallic
    • 1.4 Market Segment by Application
      • 1.4.1 Global Nanofiber Materials for Biomedical Market Share by Application (2019-2025)
      • 1.4.2 Research
      • 1.4.3 Pharmaceuticals
      • 1.4.4 Others
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Nanofiber Materials for Biomedical Production Value 2014-2025
      • 2.1.2 Global Nanofiber Materials for Biomedical Production 2014-2025
      • 2.1.3 Global Nanofiber Materials for Biomedical Capacity 2014-2025
      • 2.1.4 Global Nanofiber Materials for Biomedical Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Nanofiber Materials for Biomedical Market Size CAGR of Key Regions
      • 2.2.2 Global Nanofiber Materials for Biomedical Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Nanofiber Materials for Biomedical Capacity by Manufacturers
      • 3.1.2 Global Nanofiber Materials for Biomedical Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Nanofiber Materials for Biomedical Revenue by Manufacturers (2014-2019)
      • 3.2.2 Nanofiber Materials for Biomedical Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Nanofiber Materials for Biomedical Market Concentration Ratio (CR5 and HHI)
    • 3.3 Nanofiber Materials for Biomedical Price by Manufacturers
    • 3.4 Key Manufacturers Nanofiber Materials for Biomedical Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Nanofiber Materials for Biomedical Market
    • 3.6 Key Manufacturers Nanofiber Materials for Biomedical Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Synthetic polymers Production and Production Value (2014-2019)
      • 4.1.2 Natural polymers Production and Production Value (2014-2019)
      • 4.1.3 Ceramic and inorganic Production and Production Value (2014-2019)
      • 4.1.4 Carbon and graphene Production and Production Value (2014-2019)
      • 4.1.5 Metallic Production and Production Value (2014-2019)
    • 4.2 Global Nanofiber Materials for Biomedical Production Market Share by Type
    • 4.3 Global Nanofiber Materials for Biomedical Production Value Market Share by Type
    • 4.4 Nanofiber Materials for Biomedical Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Nanofiber Materials for Biomedical Consumption by Application

    6 Production by Regions

    • 6.1 Global Nanofiber Materials for Biomedical Production (History Data) by Regions 2014-2019
    • 6.2 Global Nanofiber Materials for Biomedical Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Nanofiber Materials for Biomedical Production Growth Rate 2014-2019
      • 6.3.2 United States Nanofiber Materials for Biomedical Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Nanofiber Materials for Biomedical Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Nanofiber Materials for Biomedical Production Growth Rate 2014-2019
      • 6.4.2 European Union Nanofiber Materials for Biomedical Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Nanofiber Materials for Biomedical Import & Export
    • 6.5 China
      • 6.5.1 China Nanofiber Materials for Biomedical Production Growth Rate 2014-2019
      • 6.5.2 China Nanofiber Materials for Biomedical Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Nanofiber Materials for Biomedical Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Nanofiber Materials for Biomedical Consumption by Regions

    • 7.1 Global Nanofiber Materials for Biomedical Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Nanofiber Materials for Biomedical Consumption by Type
      • 7.2.2 United States Nanofiber Materials for Biomedical Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Nanofiber Materials for Biomedical Consumption by Type
      • 7.3.2 European Union Nanofiber Materials for Biomedical Consumption by Application
    • 7.4 China
      • 7.4.1 China Nanofiber Materials for Biomedical Consumption by Type
      • 7.4.2 China Nanofiber Materials for Biomedical Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Nanofiber Materials for Biomedical Consumption by Type
      • 7.5.2 Rest of World Nanofiber Materials for Biomedical Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Ahlstrom
      • 8.1.1 Ahlstrom Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.1.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.1.5 Ahlstrom Recent Development
    • 8.2 Asahi Kasei
      • 8.2.1 Asahi Kasei Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.2.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.2.5 Asahi Kasei Recent Development
    • 8.3 Donaldson
      • 8.3.1 Donaldson Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.3.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.3.5 Donaldson Recent Development
    • 8.4 Nanofiber Solutions
      • 8.4.1 Nanofiber Solutions Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.4.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.4.5 Nanofiber Solutions Recent Development
    • 8.5 SNS Nanofiber Technology
      • 8.5.1 SNS Nanofiber Technology Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.5.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.5.5 SNS Nanofiber Technology Recent Development
    • 8.6 TEIJIN
      • 8.6.1 TEIJIN Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.6.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.6.5 TEIJIN Recent Development
    • 8.7 Toray
      • 8.7.1 Toray Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.7.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.7.5 Toray Recent Development
    • 8.8 3-D Matrix Medical Technology
      • 8.8.1 3-D Matrix Medical Technology Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.8.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.8.5 3-D Matrix Medical Technology Recent Development
    • 8.9 AMSilk
      • 8.9.1 AMSilk Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.9.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.9.5 AMSilk Recent Development
    • 8.10 Argonide
      • 8.10.1 Argonide Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Nanofiber Materials for Biomedical
      • 8.10.4 Nanofiber Materials for Biomedical Product Introduction
      • 8.10.5 Argonide Recent Development
    • 8.11 Collagen Matrix

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Nanofiber Materials for Biomedical Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Nanofiber Materials for Biomedical Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Nanofiber Materials for Biomedical Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Nanofiber Materials for Biomedical Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Nanofiber Materials for Biomedical Production Forecast by Type
      • 9.7.2 Global Nanofiber Materials for Biomedical Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Nanofiber Materials for Biomedical Sales Channels
      • 10.2.2 Nanofiber Materials for Biomedical Distributors
    • 10.3 Nanofiber Materials for Biomedical Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Nanomaterials, along with advancements in nanotechnology, have the potential to revolutionize existing industries and create entirely new applications. In the last decade, nanotechnology has advanced at a rapid pace, and it holds enormous prospects for biomedical applications. Nanofibers are important and versatile class of one-dimensional nanomaterials that are attracting increasing attention from academics as well as several industries in recent years. Nanofibers can be prepared from a wide range of materials such as polymers, ceramics, and metals.
      Nanofibers are proving to be an important material for applications in biomedical industry including medical filters and membranes, medical textiles, wound dressings, drug delivery, tissue engineering, and biosensors.
      The need for implants with enhanced functional life and biodegradability as one of the primary growth factors for this market. The traditional implant materials have short functional life, with failures arising from implant loosening, inflammation, infection, and wear debris. This resulted in the need for the development of new cytocompatible bone substitutes with substantially enhanced functional life to regenerate bone tissues. Titanium and its alloys are widely used in orthopedic and dental implant materials due to their compatible mechanical properties and biocompatibility.
      In 2019, the market size of Nanofiber Materials for Biomedical is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Nanofiber Materials for Biomedical.

      This report studies the global market size of Nanofiber Materials for Biomedical, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Nanofiber Materials for Biomedical production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Ahlstrom
      Asahi Kasei
      Donaldson
      Nanofiber Solutions
      SNS Nanofiber Technology
      TEIJIN
      Toray
      3-D Matrix Medical Technology
      AMSilk
      Argonide
      Collagen Matrix

      Market Segment by Product Type
      Synthetic polymers
      Natural polymers
      Ceramic and inorganic
      Carbon and graphene
      Metallic

      Market Segment by Application
      Research
      Pharmaceuticals
      Others

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Nanofiber Materials for Biomedical status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Nanofiber Materials for Biomedical manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Nanofiber Materials for Biomedical are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now